会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明申请
    • Compounds and methods for modulating cell-adhesion mediated drug resistance
    • 用于调节细胞粘附介导的耐药性的化合物和方法
    • US20080051346A1
    • 2008-02-28
    • US11731947
    • 2007-03-30
    • William DaltonJason DamianoAnne Cress
    • William DaltonJason DamianoAnne Cress
    • A61K38/08A61K38/00A61P35/00
    • A61K38/08C07K14/4747C07K14/7055A61K2300/00
    • Peptides and methods of their use for inhibiting drug and radiation-therapy resistance in cancerous cells in which efficacy of chemotherapy and/or radiotherapy of a patient is enhanced by administration of an effective amount of a peptide that inhibits cell adhesion mediated drug resistance (CAM-DR). Preferably, the peptide comprises D-amino acids having the sequence: kmviywkag(RZ-3) or is a variant or modified version thereof. The peptide is preferably administered to the patient prior to chemotherapy and/or radiation therapy. Inhibition of cell adhesion mediated drug resistance (CAM-DR) by RZ-3 in multiple myeloma cells is disclosed.
    • 肽及其用于抑制癌细胞中的药物和放射治疗抗性的方法,其中通过施用有效量的抑制细胞粘附介导的药物抗性的肽(CAM-1)来增强患者的化学疗法和/或放射疗法的功效, DR)。 优选地,肽包含具有以下序列的D-氨基酸:
      kmviywkag (RZ-3) ENTRY> 或是其变体或修改版本。 肽在化疗和/或放射治疗之前优选施用于患者。 公开了通过RZ-3在多发性骨髓瘤细胞中抑制细胞粘附介导的药物抗性(CAM-DR)。